References
- Abrams RA, Ruff JC. 1986. Oral signs and symptoms in the diagnosis of bulimia. J Am Dent Assoc 113:761–764.
- Bardow A, Pedersen AM, Nauntofte B.. Saliva. In: Miles T, Nauntofte B, Svensson P, editors. Clinical oral physiology. Copenhagen: Quintessence; 2004. p. 17–51.
- Birkhed D, Heintze U. 1989. Salivary secretion rate, buffer capacity and pH. In: Tenovuo JO, editor. Human saliva: clinical chemistry and microbiology. Vol 1. Boca Raton, FL: CRC Press; 1989. p 25–73.
- Bretz WA, Krahn DD, Drewnowski A, Loesche WJ. 1989. Salivary levels of putative cariogenic organisms In patients with eating disorders. Oral Microbiol Immunol 4:230–232.
- Bretz WA, Krahn DD, Drury M, Schork N, Loesche WJ. 1993. Effects of fluoxetine on the oral environment of bulimics. Oral Microbiol Immunol 8:62–64.
- Berkman ND, Bulik CM, Brownley KA, Lohr KN, Sedway JA, Rooks A, Gartlehner G. 2006. Management of eating disorders. Evidence Report/Technology Assessment No. 135 (Prepared by the RTI International-University of North Carolina Evidence-Based Practice Center under Contract No. 290-02-0016.) AHRQ Publication No. 06-E010. Rockville, MD: Agency for Healthcare Research and Quality.
- Burke RC. 1986. Bulimia and parotid enlargement – case report and treatment. J Otolaryng 15:49–51.
- Dynesen AW, Bardow A, Petersson B, Nielsen LR, Nauntofte B. 2008. Salivary changes and dental erosion in bulimia nervosa. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106: 696–707.
- Edgar WM. 1992. Saliva: its secretion, composition and functions. Br Dent J 172:305–312.
- Edgar M, Dawes C, O’Mullane D. 2004. Saliva and oral health. 3rd ed. London: Br Dent Assoc London.
- Fujishiro J, Imanishi T, Onozawa K, Tsushima M. 2002. Comparison of the anticholinergic effects of the serotonergic antidepressants, paroxetine, fluvoxamine and clomipramine. Eur J Pharmac 454:183–188.
- Hellstrom I. 1985. Oral complications in anorexia nervosa. Scand J Dent Res 85:71–86.
- Hunter KD, Wilson WS. 1995. The effects of antidepressant drugs on salivary flow and content of sodium and potassium ions in human parotid saliva. Arch Oral Biol 40:983–989.
- Kopittke L, Gomez R, Barros HMT. 2005. Opposite effects of antidepressants on unstimulated and stimulated salivary flow. Arch Oral Biol 50:17–21.
- Little J. 2002. Eating disorders: dental implications. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93:138–143.
- Milosevic A. 1999. Eating disorders and the dentist. Br Dent J 186(3):109–113.
- Milosevic A, Dawson LJ. 1996. Salivary differences and erosion in vomiting bulimics. Caries Res 30:361–366.
- Navazesh M. 1993. Methods for collecting saliva. Ann NY Acad Sci 694:72–77.
- Ohrn R, Angmar-Mansson B. 2000. Oral status of 35 subjects with eating disorders: 1-year study. Eur J Oral Sci 108: 275–280.
- Paszynska E, Jurga-Krokowicz J, Shaw H.2006. The use of parotid gland activity analysis in patients with gastro-esophageal reflux disease (GERD) and bulimia nervosa. Adv Med Sci 51:208–213.
- Riad M, Barton JR, Wilson JA, Freeman CPL, Maran AGD. 1991. Parotid salivary secretory pattern in bulimia nervosa. Acta Otolaryngol 111:392–395.
- Richelson E. 1983. Antimuscarinic and other receptor-blocking properties of antidepressants. Mayo Clin Proc 58: 40–46.
- Romano SJ, et al. 2002. A placebo-controlled study of fluoxetine in continued treatment of bulimia nervosa after acute fluo xetine treatment. Am J Psychiatry 159:96–102.
- Rossi A, Barraco A, Donda P. 2004. Fluoxetine: a review on evidence based medicine. Ann Gen Hospital Psychiatry 3:2–8.
- Schleuter N, Ganns C, Potschke S, Klimek J, Hannig C. 2012. Enzyme activities in the oral fluids of patients suffering from bulimia: a controlled clinical trial. Caries Res 46: 130–139.
- Ship JA, Fisher DJ. 1999. Metabolic indicators of hydration status in the prediction of parotid salivary-gland function. Arch Oral Biol 44:343–350.
- Tylenda CA, Roberts MW, Elin BJ, Li SH, Altemus M. 1991. Bulimia nervosa its effect on salivary chemistry. J Am Dent Assoc 122:37–41.